Angiodynamics

Eximo Medical Ltd. is an innovative company based in Modi'in-Maccabim-Re'ut, Israel, specializing in hybrid catheter technology for tissue resection in vascular and gastrointestinal endoluminal applications. Founded in 2012, Eximo has developed a proprietary single-use hybrid catheter known as CatHI, which integrates optical fibers that emit short laser pulses and a blunt mechanical knife. This advanced technology aims to enhance safety and performance during medical procedures, particularly in atherectomy, by minimizing the risk of vessel perforation. As of October 2019, Eximo Medical operates as a subsidiary of AngioDynamics, Inc.

RadiaDyne, established in 2007 and headquartered in Houston, Texas, is a medical diagnostic and device company. It specializes in designing and developing patient dose monitoring technology for cancer patients undergoing radiation treatments. The company's core offering is a radiation dose monitoring platform that ensures accurate dose readings, real-time pinpoint measurement, and utilizes proprietary delivery devices, aiming to enhance cancer patients' radiation therapy experience with reduced side effects and improved outcomes. As of 2018, RadiaDyne operates as a subsidiary of AngioDynamics, Inc.

Vortex Medical is a medical device company focused on the design, development and commercialization.

Navilyst Medical Inc., based in Marlborough, Massachusetts, specializes in the manufacturing of medical devices, particularly focusing on dialysis catheters, drainage catheters, fluid management products, and vascular accessories. Established in February 2008 from the Fluid Management and Vascular Access divisions of Boston Scientific, the company has developed innovative technologies such as the PASV Valve Technology and the Xcela Power Injectable PICCs, which are designed to enhance patient safety and improve clinical outcomes. Navilyst Medical distributes its products globally, with its primary manufacturing facility located in Glens Falls, New York. The company's name reflects its commitment to navigating and catalyzing advancements in the medical technology sector.

FlowMedica is a medical device company specializing in intravascular systems for Targeted Renal Therapy. The company develops innovative solutions aimed at addressing kidney dysfunction associated with cardiovascular disease, cancer, and surgical procedures. Its flagship product, the Benephit CV Infusion System, enables physicians to deliver therapeutic agents directly into the renal arteries through an infusion catheter, facilitating simultaneous coronary procedures via a single access point in the femoral artery. Additionally, the Benephit XTMini Infusion System caters to patients with smaller vascular anatomies by allowing bilateral infusion to the kidneys. FlowMedica's devices present a precise alternative to traditional systemic intravenous infusion methods, enabling surgeons to administer treatments directly and accurately.

RITA Medical Systems develops, manufactures and markets innovative products for patients with solid cancerous or benign tumors. The proprietary RITA system uses radiofrequency energy to heat tissue to a high enough temperature to ablate it or cause cell death. While the Company's current focus is on liver cancer and metastatic bone cancer, the Company believes that its minimally invasive technology may in the future be applied to other types of tumors, including tumors of the lung, breast, uterus, prostate and kidney. The Company has received regulatory clearance in major markets worldwide, including the United States. In March 2000, RITA became the first radiofrequency ablation company to receive specific FDA clearance for unresectable liver lesions in addition to its previous general FDA clearance for the ablation of soft tissue. In October 2002, RITA again became the first company to receive specific FDA clearance, this time, for the palliation of pain associated with metastatic lesions involving bone. The Company has sold over 40,000 of its disposable devices throughout the world.